FC
FELDMANN CYNTHIA L
Director
BoardF
Insider track record
Board DirectorAcross 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by FELDMANN CYNTHIA L, Director. Officer active across 4 companies, notably STERIS plc. In total, 18 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €211k. History available since 25 May 2021. The latest transaction was disclosed on 28 February 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations18 total
2,756 shares@ US$38.6124.7% of flowCommon Stock, $.01 Par ValueSEC:0001062993-25-004478:0
2,032 shares0Common StockSEC:0001035443-25-000047:0
647 shares@ US$352.3050.9% of flowCommon Stock, $.01 Par ValueSEC:0001062993-24-018699:0
230 shares0Common Stock, $.01 Par ValueSEC:0001062993-24-012215:0
2,000 shares@ US$86.2324.0% of flowOrdinary SharesSEC:0001628280-24-024092:0
1,724 shares@ US$31.2012.0% of flowCommon Stock, $.01 Par ValueSEC:0001062993-24-004652:0
1,585 shares0Common StockSEC:0001035443-24-000055:0
298 shares0Common Stock, $.01 Par ValueSEC:0001062993-23-013199:0
2,056 shares@ US$27.0512.4% of flowCommon Stock, $.01 Par ValueSEC:0001062993-23-012069:0
2,058 shares@ US$86.2324.7% of flowOrdinary SharesSEC:0001209191-23-030650:0
1,125 shares0Common StockSEC:0001035443-23-000079:0
647 shares0Common Stock, $.01 Par ValueSEC:0001240679-22-000042:0
1,000 shares0Common StockSEC:0001035443-22-000082:0
1,891 shares@ US$71.400.0006% mcap34.9% of flowOrdinary SharesSEC:0001209191-22-009392:0
610 shares0Common Stock, $.01 Par ValueSEC:0001240679-21-000043
610 shares0Common Stock, $.01 Par ValueSEC:0001240679-21-000043:0
2,110 shares@ US$64.050.0005% mcap32.6% of flowOrdinary SharesSEC:0001209191-21-035936:0
2,110 shares@ US$64.0532.6% of flowOrdinary SharesSEC:0001209191-21-035936
About FELDMANN CYNTHIA L
Cynthia L. Feldmann is a Board Member at Steris plc and UFP Technologies Inc. As a board member, she participates in the governance and strategic decision-making of the companies. Her experience in the medical technology sector allows her to provide valuable insights for the companies' development. Cynthia Feldmann plays an active role in evaluating performance and growth opportunities.